Exploratory Study : to Evaluate the Panty MOBIDERM in Patients With Pelvic and/or Genital Lymphedema

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

July 9, 2021

Study Completion Date

July 9, 2021

Conditions
Lymphedema of Genitalia
Interventions
DEVICE

MOBIDERM Panty group

"In the MOBIDERM Panty group, patients wear the MOBIDERM Panty during day and night for 3 months with the possibility to add the PAD.~The protocol includes 3 visits.~Visit 1 at day 0, corresponding to the inclusion visit, includes device delivery and some clinical evaluations (clinical examination, characteristics of lymphedema, self questionnaires, pain assessment, perimeter data).~Visit 2 at 30 days after the inclusion : includes some clinical evaluations (clinical examination, characteristics and evolution of lymphedema, self questionnaires, pain assessment, perimeter data, safety, compliance).~Visit 3 at 90 days after the inclusion : includes some clinical evaluations (clinical examination, characteristics and evolution of lymphedema, self questionnaires, pain assessment, perimeter data, safety, compliance)."

Trial Locations (3)

34295

CHU Montpellier - Hôpital St Eloi - Service Maladies Vasculaires, Montpellier

75015

Hôpital Cognacq-Jay - unité de lymphologie, Paris

Unknown

CHU TOULOUSE - service médecine vasculaire, Toulouse

All Listed Sponsors
lead

Thuasne

INDUSTRY

NCT04602559 - Exploratory Study : to Evaluate the Panty MOBIDERM in Patients With Pelvic and/or Genital Lymphedema | Biotech Hunter | Biotech Hunter